IMPACT OF HELICOBACTER PYLORI ON EARLY POSTOPERATIVE COMPLICATIONS AFTER SLEEVE GASTRECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD
Citação
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, v.36, article ID e1788, 6p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The impact of Helicobacter pylori (HP) on postoperative outcomes after sleeve gastrectomy (SG) is still controversial. A systematic review and meta-analysis were performed to compare the incidence of early complications after SG between HP-positive and HP-negative patients. Eight retrospective comparative studies were included, comprising 4,877 individuals. The prevalence of HP infection in gastric resected specimens ranged from 7.77 to 43.20%. There were no statistically significant differences between groups for overall complications (OR 1.46; 95%CI 0.95-2.23; p=0.08), bleeding (OR 1.35; 95%CI 0.70-2.60; p=0.38), and leak (OR 1.74; 95%CI 0.80-3.81; p=0.17) rates. The need for routine screening and treatment of HP infection before SG remains ambiguous.
Palavras-chave
Bariatric Surgery, Helicobacter Pylori, Postoperative Complications
Referências
  1. Abu Abeid A, 2022, OBES SURG, V32, P1617, DOI 10.1007/s11695-022-05996-z
  2. Almazeedi S, 2014, OBES SURG, V24, P412, DOI 10.1007/s11695-013-1108-7
  3. Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013
  4. Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040
  5. Brown WA, 2020, OBES SURG, V30, P3135, DOI 10.1007/s11695-020-04720-z
  6. Brownlee A, 2015, OBES SURG, V25, P2276, DOI 10.1007/s11695-015-1687-6
  7. Chiappetta S, 2023, OBES SURG, V33, P1449, DOI 10.1007/s11695-023-06481-x
  8. Emile SH, 2020, OBES SURG, V30, P3037, DOI 10.1007/s11695-020-04648-4
  9. Ergin A, 2021, OBES SURG, V31, P4024, DOI 10.1007/s11695-021-05513-8
  10. Erim T, 2008, WORLD J SURG, V32, P2021, DOI 10.1007/s00268-008-9608-7
  11. Goday A, 2018, OBES SURG, V28, P2386, DOI 10.1007/s11695-018-3170-7
  12. de las Heras SGG, 2021, OBES RES CLIN PRACT, V15, P289, DOI 10.1016/j.orcp.2021.05.002
  13. Gonzalez-Heredia R, 2015, BARIATR SURG PRACT P, V10, P15, DOI 10.1089/bari.2014.0045
  14. Hashimoto K, 2022, OBES SURG, V32, P3404, DOI 10.1007/s11695-022-06253-z
  15. Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022
  16. Kelly JJ, 2015, SURG ENDOSC, V29, P2885, DOI 10.1007/s00464-014-4022-8
  17. Kountouras J, 2018, METABOLISM, V87, P18, DOI 10.1016/j.metabol.2018.06.008
  18. Malfertheiner P, 2022, GUT, V71, P1724, DOI 10.1136/gutjnl-2022-327745
  19. Mocanu V, 2018, OBES SURG, V28, P567, DOI 10.1007/s11695-017-3024-8
  20. Page MJ, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003583
  21. Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999
  22. Rhodes K, 2017, SPORTS MED, V47, P1619, DOI 10.1007/s40279-017-0677-3
  23. Rossetti G, 2014, INT J SURG, V12, pS68, DOI 10.1016/j.ijsu.2014.05.051
  24. Sawathanon S, 2023, SURG ENDOSC, V37, P2202, DOI 10.1007/s00464-022-09391-8
  25. Schulman AR, 2017, OBESITY, V25, P522, DOI 10.1002/oby.21759
  26. Serin KR, 2018, TURK J GASTROENTEROL, V29, P379, DOI 10.5152/tjg.2018.17373
  27. Shahraki MS, 2021, OBES SURG, V31, P4210, DOI 10.1007/s11695-021-05507-6
  28. Shanti H, 2017, OBES SURG, V27, P1298, DOI 10.1007/s11695-016-2470-z
  29. Silva MBDE, 2021, ABCD-ARQ BRAS CIR DI, V34, DOI 10.1590/0102-672020210002e1626
  30. Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
  31. Valezi AC, 2023, ABCD-ARQ BRAS CIR DI, V36, DOI 10.1590/0102-672020230041e1759
  32. Xu X, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.937887